Imagion Biosystems December 2021 Investor Newsletter
December 16, 2021
We are pleased to provide our investors with our December 2021 Investor Newsletter. In this edition, our Executive Director and CEO Bob Proulx gives an
Category: Investor updates
IBXO Options Exercise Complete
December 1, 2021
Imagion Biosystems is pleased to advise that it has now received the full $4.8 million from the exercise of all 96,706,395 listed options (IBXO) which
Appendix 2A — Application for Quotation of +Securities
December 1, 2021
The following Appendix 2A was announced via ASX on 1 Dec 2021. Please click to review full announcement.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
December 1, 2021
The following cleansing notice was lodged with ASX on December 1, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 26 November
Appendix 2A Application for quotation of +securities
November 25, 2021
The following Appendix 2A was announced via ASX on 25 Nov 2021. Please click to review full announcement.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
November 25, 2021
The following cleansing notice was lodged with ASX on November 25, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 19 November
IBXO Options Underwriting Agreement — US Based Investor
November 24, 2021
Imagion Biosystems is pleased to announce it has entered into an options underwriting agreement (Underwriting Agreement) with Mercer Street Global Opportunity Fund LLC (Underwriter), a
Appendix 3Y Change of Director’s Interest Notice
November 22, 2021
The document “Appendix 3Y Change of Director’s Interest Notice” was lodged with ASX on 22 November, 2021. Please click to review the full announcement at
Application for quotation of +securities
November 18, 2021
The document “Application for quotation of +securities” was lodged with ASX on November 18, 2021. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
November 18, 2021
The following cleansing notice was lodged with ASX on 18 November 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 12 November